Dermatologists at Yale University say tofacitinib citrate, an oral rheumatoid arthritis drug, allowed an alopecia patient to grow a full head of hair.
The American Food and Drug Administration (FDA) has released a draft of guidelines for pharmaceutical companies to adhere to when using social media.
In the draft, the FDA said that companies must be sure to disclose the “most serious risks” when discussing the benefits of their products on social media sites, as well as specifying precise indications for each product.
The aesthetic manufacturer, Cynosure, has announced today that they have received FDA clearance to market PicoSure Focus for the treatment of acne scars.
The treatment uses laser technology that claims to revitalise the skin and erase imperfections in just 30 minutes.
William Ackman, the CEO of Allergan’s largest shareholder, Pershing Square Capital Management, has sent an open letter to Allergan criticising their attitude towards Valeant and urging them to not delay a shareholders meeting.
The second part of a public consultation on the revision of the Nursing and Midwifery standard of good practice will close on August 11.
Galderma has now gained full rights to distribute Restylane, Emervel, Sculptra and Dysport in the US, from Valeant Pharmaceuticals International. Galderma will aim to distribute the acquired products through the existing distribution partner.
AesthetiCare has been announced as the exclusive UK distributor for all Dermalux systems, commencing September 1, 2014. Aesthetic Technology Ltd, creators of Dermalux LED systems, announced the partnership with AesthetiCare ahead of the launch of their new Tri Wave Portable system.
Huw Anthony, managing director of Aesthetic Technology, said, “Our business has enjoyed significant growth over the past couple of years with Dermalux LED systems now installed in over 170 clinics throughout the UK and also a number overseas. With the imminent launch of our brand new Tri Wave Portable system and further exciting developments to come over the next couple of years we felt the need to strengthen our position by partnering with a forward thinking and respected company within the industry.
International pharmaceutical company Merz will buy US-based medical device company Ulthera for $600 million in upfront cash and milestone payments.
Market research company, Research and Markets has launched a new report: Facial Aesthetics Market to 2020 – Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets.
Dermatologist Dr Howard Murad has received the lifetime achievement award at The Aesthetic Show’s annual awards ceremony in Las Vegas.
The Fellow of the American Academy of Dermatology (FAAD) accepted the Aesthetic Visionary Award, which recognised his contribution to research, science, healthy living and skincare.
Chicago-based researchers claim mobile apps are an effective method of distributing medical information.
After creating a free app that conveyed evidence-based content on diet and acne, the team found it was downloaded to 5507 devices in 98 countries.
A new book written by Dr Terry Loong, medical director of the Skin Energy Clinic in London, promises to help cure acne without pills.
A key finding of a new study in Philadelphia has explained how injecting onabotulinumA (BoNT –A) into the scalp can prevent or reverse mechanical sensitization of meningeal nociceptors in migraine.